Jennifer Chunias is a partner in Goodwin’s Securities Litigation & White Collar Defense group. She concentrates in the areas of government and internal investigations, including by the Department of Justice, the U.S. Securities and Exchange Commission, the Massachusetts Securities Division, and FINRA, in relation to alleged health care fraud, financial accounting improprieties, securities fraud, insider trading, visa fraud, export violations, and alleged violations of the Foreign Corrupt Practice Act (FCPA) and False Claims Act (FCA); stockholder, founder, and partnership disputes; private equity and venture capital post-closing and working capital disputes; and higher education litigation.

Ms. Chunias’ clients include public and private healthcare, life sciences, and technology companies, their boards and officers, private equity and venture capital firms and their partners, and prominent universities.

Ms. Chunias has conducted dozens of internal corporate investigations for audit committees and other special board committees into financial accounting and corporate governance-related matters, including whistleblower matters under Sarbanes-Oxley and Dodd-Frank.

Ms. Chunias routinely works with clients on the development and implementation of appropriate policies and remedial actions identified during corporate investigations, and advises private equity and venture capital clients on corporate governance issues and best practices for portfolio company board service.





Among her recent matters, Ms. Chunias’s representations include:

  • A global technology company in connection with civil False Claim Act qui tam litigation and criminal investigations by the U.S. Attorney's Office and the U.S. Department of Justice, National Security Division, relating to defense contracts and allegations of visa fraud, contract fraud, and ITAR violations.
  • Research misconduct investigations and related litigation on behalf of universities and research institutions. Such representations have included the successful dismissal of a federal lawsuit challenging an institutional research misconduct investigation on behalf of Harvard Medical School.
  • Various technology companies and private equity portfolio companies in post-closing disputes, government inquiries, and internal investigations.
  • Various venture capital firms and their partners in connection with partnership disputes and dissolution, as well as investment-related post-closing matters.
  • The Special Board Committee of a public medical technology company in relation to an internal investigation of whistleblower allegations of FCPA violations and bribery relating to import of company products into Russia and Eastern Europe.
  • A U.S.-based global manufacturer of scientific instruments and medical devices in connection with investigations by the SEC, DOJ and Hong Kong Independent Commission Against Corruption into alleged bribery and corruption violations at several of the Company's China subsidiaries, including relating to the use of third-party intermediaries in connection with contracts with state-owned entities.
  • A financial consulting firm in False Claim Act and class action litigation arising out of “pay-to-play” allegations relating to the New Mexico State pension system.
  • The former CEO of a pharmaceutical and medical device company in connection with a federal indictment relating to the company's sale of allegedly unapproved and adulterated drugs, successfully arguing for a significant downward departure following the entry of a guilty plea.
  • A private healthcare consulting firm in connection with multiple FCA qui tam whistleblower suits arising out of allegations that the company assisted hospitals seeking and receiving inflated Medicare and Medicaid reimbursements.
  • A national pension consulting firm in connection with claims relating to the Madoff Ponzi scheme.
  • The former president of a publicly-traded home healthcare company in connection with an investigation by the DOJ, successfully arguing for a significant downward departure following entry of a guilty plea on charges of money laundering and filing false tax returns.
Professional Activities

In 2016, Ms. Chunias was appointed by Massachusetts Governor Charlie Baker to the State Ballot Law Commission.

Ms. Chunias has served on the Board of the Women's Bar Foundation, on the BBA's Individual Rights Responsibilities Section Steering Committee, and as a pro bono Bar Advocate, handling dozens of court appointments in the Criminal Division of the Boston Municipal Court.

Professional Experience

Prior to joining Goodwin in 2005, Ms. Chunias was a lecturer at Harvard Law School. Before that, she was an associate in the Litigation Practice Group at Testa, Hurwitz & Thibeault, LLP in Boston.


Ms. Chunias is listed in Global Investigations Review 100, a guide to the world’s leading firms for corporate investigations. In 2009, Ms. Chunias was selected by the Boston Business Journal as one of the top 40 business leaders in Massachusetts under the age of 40 and honored at a "Women of Justice" event by Massachusetts Lawyers Weekly, the Women's Bar Association and the Massachusetts Association of Women Lawyers. She also was selected as an "Up and Coming Lawyer" for 2005 by Massachusetts Lawyers Weekly and named a Massachusetts Super Lawyer "Rising Star" in 2006, 2007, 2008 and 2009.

In The News









Northeastern University School of Law
The University of Vermont





U.S. District Court of Connecticut
U.S. District Court for the District of Massachusetts
Get In Touch
German Translation
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique